Cargando…
Energy disruptors: rising stars in anticancer therapy?
The metabolic features of tumor cells diverge from those of normal cells. Otto Warburg was the first to observe that cancer cells dramatically increase their glucose consumption to generate ATP. He also claimed that cancer cells do not have functional mitochondria or oxidative phosphorylation (OXPHO...
Autores principales: | Bost, F, Decoux-Poullot, A-G, Tanti, J F, Clavel, S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728676/ https://www.ncbi.nlm.nih.gov/pubmed/26779810 http://dx.doi.org/10.1038/oncsis.2015.46 |
Ejemplares similares
-
The energy disruptor metformin targets mitochondrial integrity via modification of calcium flux in cancer cells
por: Loubiere, Camille, et al.
Publicado: (2017) -
Critical Overview on Endocrine Disruptors in Diabetes Mellitus
por: Hinault, Charlotte, et al.
Publicado: (2023) -
Rising Star
por: Wojtys, Edward M.
Publicado: (2012) -
NK Cell Therapy: A Rising Star in Cancer Treatment
por: Du, Nawen, et al.
Publicado: (2021) -
RISING STARS: Targeting G protein-coupled receptors to regulate energy homeostasis
por: Jamaluddin, Aqfan, et al.
Publicado: (2023)